YH
Highly rated in
27
conditions
Highly rated in
27
conditions
Check Dr. Ying J. Hitchcock's experience treating your condition:
About Dr. Ying J. Hitchcock

Ying Hitchcock is a Radiation Oncologist in Salt Lake City, Utah. Hitchcock has been practicing medicine for over 38 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, Tongue Cancer, Salivary Gland Tumors, and Gamma Knife Radiosurgery. She is licensed to treat patients in Utah. Hitchcock is currently accepting new patients.

Her clinical research consists of co-authoring 68 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Ying J. Hitchcock it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Ying J. Hitchcock accepts the following insurance:

  •  Ambetter
  •  Molina Healthcare
  •  Montana Health Cooperative
  •  Regence
  •  University of Utah Health
  •  BridgeSpan
Locations
Salt Lake City, UT 84112
Background & Education
Graduate Institution
Other, 1985
Specialties
Radiation Oncology
Licenses
Radiology in UT
Hospital Affiliations
University Of Utah Hospital
Primary Childrens Hospital
George E Wahlen Department Of Veterans Affairs Medical Center
Languages Spoken
English
Chinese
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors